Echinacea Purpurea and Osteopathy in Children With Recurrent Otitis Media
Echinacea Purpurea and Cranial Osteopathic Manipulative Treatment in Children With Recurrent Otitis Media: a Randomized Controlled Trial.
2 other identifiers
interventional
90
1 country
3
Brief Summary
This study was designed to evaluate the efficacy of the herb Echinacea purpurea and of cranial osteopathic manipulative treatment to prevent otitis media (middle ear infections) in young children.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 1999
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 1999
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2002
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2002
CompletedFirst Submitted
Initial submission to the registry
May 30, 2008
CompletedFirst Posted
Study publicly available on registry
June 3, 2008
CompletedJune 3, 2008
May 1, 2008
3.2 years
May 30, 2008
May 30, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The occurrence of a first episode of acute otitis media during the study period.
Six months
Secondary Outcomes (1)
The total number of episodes of diagnosed acute otitis media during the study period.
Six months
Study Arms (4)
1
PLACEBO COMPARATOROsteopathic sham treatment plus placebo "Echinacea" drops
2
ACTIVE COMPARATORActive Echinacea drops plus sham osteopathic treatment
3
ACTIVE COMPARATORActive osteopathic manipulation plus placebo "Echinacea" drops
4
ACTIVE COMPARATORActive osteopathic manipulation plus active Echinacea drops.
Interventions
A series of five cranial osteopathic manipulative treatment sessions scheduled over three months, and provided by osteopathic physicians whose practices are limited to osteopathic manipulative treatment. Treatment modalities were limited to cranial osteopathy, balanced membranous/ligamentous tension, and/or myofascial release (applied directly or indirectly).
1:1 weight-to-volume 50% ethanol liquid extract of the fresh roots and dried mature seeds of Echinacea purpurea. Dosage: 0.5 ml orally 3 times daily for 3 days at the onset of cold symptoms, followed by 0.25 ml orally 3 times daily for 7 more days.
Sham osteopathic treatment consisted of a series of five osteopathic examinations only (palpation of the cranial bones and muscles and other structures) without treatment maneuvers.
An identically labeled placebo contained 50% ethanol, 45% filtered water, food coloring and thickeners. Dosage: 0.5 ml orally 3 times daily for 3 days at the onset of cold symptoms, followed by 0.25 ml orally 3 times daily for 7 more days.
Eligibility Criteria
You may qualify if:
- or more separate episodes of acute otitis media within a 6 month period, or
- episodes of acute otitis media in one year,
You may not qualify if:
- Congenital malformations of the ears, nose, or throat
- Known or suspected allergy to echinacea
- Immune deficiency including HIV infection
- Tuberculosis
- Current use of prophylactic antibiotics
- Tympanostomy tubes in place
- Unwillingness of child to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Pediatric Osteopathic Center
Tucson, Arizona, 85712, United States
KateCare Osteopathic Center
Tucson, Arizona, 85719, United States
Pediatric Clinic, Arizona Health Sciences Center
Tucson, Arizona, 85724-5073, United States
Related Publications (1)
Mark JD, Grant KL, Barton LL. The use of dietary supplements in pediatrics: a study of echinacea. Clin Pediatr (Phila). 2001 May;40(5):265-9. doi: 10.1177/000992280104000505.
PMID: 11388676BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Richard A Wahl, MD
University of Arizona
- PRINCIPAL INVESTIGATOR
Michael B Aldous, MD, MPH
University of Arizona
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
May 30, 2008
First Posted
June 3, 2008
Study Start
July 1, 1999
Primary Completion
September 1, 2002
Study Completion
October 1, 2002
Last Updated
June 3, 2008
Record last verified: 2008-05